{
 "awd_id": "1831084",
 "agcy_id": "NSF",
 "tran_type": "Grant",
 "awd_istr_txt": "Standard Grant",
 "awd_titl_txt": "SBIR Phase II:  Dynamic Nanopores Enabling Non-toxic Cryopreservation to Advance Centralized Manufacturing & Transport of Regenerative Medicines",
 "cfda_num": "47.084",
 "org_code": "15030000",
 "po_phone": "7032927069",
 "po_email": "hahn@nsf.gov",
 "po_sign_block_name": "Henry Ahn",
 "awd_eff_date": "2018-09-01",
 "awd_exp_date": "2022-10-31",
 "tot_intn_awd_amt": 743322.0,
 "awd_amount": 1243322.0,
 "awd_min_amd_letter_date": "2018-09-04",
 "awd_max_amd_letter_date": "2021-10-06",
 "awd_abstract_narration": "This Small Business Innovation Research Phase II project will continue development of cutting-edge nanopore technology that will greatly enhance biological preservation of regenerative medicines such as stem cells, complex tissues, and organs. Such a technology has the potential to greatly improve the biobanking and transport infrastructure of healthcare for on-demand cells and tissues, improved mass trauma care and advanced personalized medical procedures. Biopreservation is required in regenerative medicine at nearly all levels in the acquisition of source material, isolation, storage and shipment of a final product to patient. Yet critically, the field lacks the ability to safely and efficiently preserve these tissues and medicines while maintaining high cell viability and function after cryopreservation, severely limiting product shelf life. Nowhere is the absence of a biobanking technology more palpable than organ transplantation, where the time window between donor and recipient (4-7 hours) is not enough to properly match donations, screen for pathogens, or transport long distances. Enabling the United States to safely bank organs at subzero temperature will significantly enhance national healthcare. The US faces strong commercial and competitiveness reasons to invest in all facets of regenerative medicine, including organ therapies. Cryopreservation solutions would indirectly enable significant savings to the healthcare system, the patient, and healthcare insurance companies with the cost savings from regenerative medicine treatments estimated to be nearly $250 billion per year in the U.S.\r\n\r\n\r\n\r\nThe cytotoxicity of current biopreservation techniques is largely associated with inefficient cryoprotective agent and water delivery across the cell membrane during cooling leading to irreparable cell damage from ice formation. Phase I established a fundamentally different approach to cryoprotective agent (CPA) optimization by developing first-in-the-field bioinspired nanopores as transmembrane mega highways to facilitate safe and efficient intracellular delivery and removal of cryoprotective agents during cryopreservation and dramatically increase post-thaw cell yield, viability, and function. The pore-formers assist CPA loading at reduced temperatures to make up the functional loss of biological protein channels at cold temperatures, reduce the amount of CPA required to remarkably low concentrations, and expand the selectable range of CPAs, all while dynamically dissociating at physiological temperature to prevent open-pore toxicity. Further R&D effort will diversify molecular design, optimize lead molecules, scale-up production, and perform cryopreservation studies on regenerative medicines of major therapeutic significance such as stem cells and complex tissues.\r\n\r\nThis award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.",
 "awd_arra_amount": 0.0,
 "dir_abbr": "TIP",
 "org_dir_long_name": "Directorate for Technology, Innovation, and Partnerships",
 "div_abbr": "TI",
 "org_div_long_name": "Translational Impacts",
 "awd_agcy_code": "4900",
 "fund_agcy_code": "4900",
 "pi": [
  {
   "pi_role": "Principal Investigator",
   "pi_first_name": "Xiaoxi",
   "pi_last_name": "Wei",
   "pi_mid_init": "",
   "pi_sufx_name": "",
   "pi_full_name": "Xiaoxi Wei",
   "pi_email_addr": "xwei@x-therma.com",
   "nsf_id": "000713677",
   "pi_start_date": "2018-09-04",
   "pi_end_date": null
  }
 ],
 "inst": {
  "inst_name": "X-Therma Inc.",
  "inst_street_address": "625B ALFRED NOBEL DR",
  "inst_street_address_2": "",
  "inst_city_name": "HERCULES",
  "inst_state_code": "CA",
  "inst_state_name": "California",
  "inst_phone_num": "8143311109",
  "inst_zip_code": "945471815",
  "inst_country_name": "United States",
  "cong_dist_code": "08",
  "st_cong_dist_code": "CA08",
  "org_lgl_bus_name": "X-THERMA INC.",
  "org_prnt_uei_num": "MKP9GFAJNEY9",
  "org_uei_num": "MKP9GFAJNEY9"
 },
 "perf_inst": {
  "perf_inst_name": "X-Therma Inc.",
  "perf_str_addr": "2600 Hilltop Drive, Suite B220",
  "perf_city_name": "Richmond",
  "perf_st_code": "CA",
  "perf_st_name": "California",
  "perf_zip_code": "948061971",
  "perf_ctry_code": "US",
  "perf_cong_dist": "08",
  "perf_st_cong_dist": "CA08",
  "perf_ctry_name": "United States",
  "perf_ctry_flag": "1"
 },
 "pgm_ele": [
  {
   "pgm_ele_code": "537300",
   "pgm_ele_name": "SBIR Phase II"
  }
 ],
 "pgm_ref": [
  {
   "pgm_ref_code": "165E",
   "pgm_ref_txt": "SBIR Phase IIB"
  },
  {
   "pgm_ref_code": "5373",
   "pgm_ref_txt": "SMALL BUSINESS PHASE II"
  },
  {
   "pgm_ref_code": "7573",
   "pgm_ref_txt": "BIO-RELATED MATERIALS RESEARCH"
  },
  {
   "pgm_ref_code": "8029",
   "pgm_ref_txt": "Manufacturing"
  }
 ],
 "app_fund": [
  {
   "app_code": "0118",
   "app_name": "NSF RESEARCH & RELATED ACTIVIT",
   "app_symb_id": "040100",
   "fund_code": "01001819DB",
   "fund_name": "NSF RESEARCH & RELATED ACTIVIT",
   "fund_symb_id": "040100"
  },
  {
   "app_code": "0121",
   "app_name": "NSF RESEARCH & RELATED ACTIVIT",
   "app_symb_id": "040100",
   "fund_code": "01002122DB",
   "fund_name": "NSF RESEARCH & RELATED ACTIVIT",
   "fund_symb_id": "040100"
  }
 ],
 "oblg_fy": [
  {
   "fund_oblg_fiscal_yr": 2018,
   "fund_oblg_amt": 743322.0
  },
  {
   "fund_oblg_fiscal_yr": 2021,
   "fund_oblg_amt": 500000.0
  }
 ],
 "por": {
  "por_cntn": "<div class=\"porColContainerWBG\">\n<div class=\"porContentCol\"><p><span class=\"TextRun Highlight SCXW141900476 BCX9\" style=\"margin: 0px; padding: 0px; user-select: text; outline: transparent solid 1px; font-variant-ligatures: none !important; color: #000000; font-style: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; white-space: pre-wrap; widows: 2; word-spacing: 0px; background-color: #ffffff; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 11pt; line-height: 17px; font-family: Arial, Arial_EmbeddedFont, Arial_MSFontService, sans-serif;\" lang=\"EN-US\"><span class=\"NormalTextRun SCXW141900476 BCX9\" style=\"margin: 0px; padding: 0px; user-select: text;\">Organ transplantation emerged as a paradigm shift in the treatment of end stage disease when the first kidney transplantation was performed in 1954. Today, the field of organ transplantation has become sophisticated, and patients are now able to benefit from a nationwide organ transplant waiting list currently totaling more than 105,000 individuals.</span></span></p>\n<p><span class=\"TextRun Highlight SCXW141900476 BCX9\" style=\"margin: 0px; padding: 0px; user-select: text; outline: transparent solid 1px; font-variant-ligatures: none !important; color: #000000; font-style: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; white-space: pre-wrap; widows: 2; word-spacing: 0px; background-color: #ffffff; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 11pt; line-height: 17px; font-family: Arial, Arial_EmbeddedFont, Arial_MSFontService, sans-serif;\" lang=\"EN-US\"><span class=\"NormalTextRun SCXW141900476 BCX9\" style=\"margin: 0px; padding: 0px; user-select: text;\">Organ- and tissue- </span><span class=\"NormalTextRun SCXW141900476 BCX9\" style=\"margin: 0px; padding: 0px; user-select: text;\">preservation and transport</span><span class=\"NormalTextRun SCXW141900476 BCX9\" style=\"margin: 0px; padding: 0px; user-select: text;\"> is often overlooked, despite a narrow time window that must be adhered to for transplantation success. <span class=\"TextRun Highlight SCXW141900476 BCX9\" style=\"margin: 0px; padding: 0px; user-select: text; outline: transparent solid 1px; font-variant-ligatures: none !important; color: #000000; font-style: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; white-space: pre-wrap; widows: 2; word-spacing: 0px; background-color: #ffffff; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 11pt; line-height: 17px; font-family: Arial, Arial_EmbeddedFont, Arial_MSFontService, sans-serif;\" lang=\"EN-US\"><span class=\"NormalTextRun SCXW141900476 BCX9\" style=\"margin: 0px; padding: 0px; user-select: text;\">The quality of organ preservation </span></span><span class=\"TextRun SCXW141900476 BCX9\" style=\"margin: 0px; padding: 0px; user-select: text; font-variant-ligatures: none !important; color: #000000; font-style: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; white-space: pre-wrap; widows: 2; word-spacing: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 11pt; line-height: 17px; font-family: Arial, Arial_EmbeddedFont, Arial_MSFontService, sans-serif;\" lang=\"EN-US\"><span class=\"NormalTextRun SCXW141900476 BCX9\" style=\"margin: 0px; padding: 0px; user-select: text;\">could be the </span><span class=\"NormalTextRun SCXW141900476 BCX9\" style=\"margin: 0px; padding: 0px; user-select: text;\">factor that differentiates a </span><span class=\"NormalTextRun SCXW141900476 BCX9\" style=\"margin: 0px; padding: 0px; user-select: text;\">successful </span><span class=\"NormalTextRun SCXW141900476 BCX9\" style=\"margin: 0px; padding: 0px; user-select: text;\">therapy from a </span><span class=\"NormalTextRun SCXW141900476 BCX9\" style=\"margin: 0px; padding: 0px; user-select: text;\">failed </span><span class=\"NormalTextRun SCXW141900476 BCX9\" style=\"margin: 0px; padding: 0px; user-select: text;\">one, and better </span></span><span class=\"TextRun Highlight SCXW141900476 BCX9\" style=\"margin: 0px; padding: 0px; user-select: text; outline: transparent solid 1px; font-variant-ligatures: none !important; color: #000000; font-style: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; white-space: pre-wrap; widows: 2; word-spacing: 0px; background-color: #ffffff; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 11pt; line-height: 17px; font-family: Arial, Arial_EmbeddedFont, Arial_MSFontService, sans-serif;\" lang=\"EN-US\"><span class=\"NormalTextRun SCXW141900476 BCX9\" style=\"margin: 0px; padding: 0px; user-select: text;\">preservation techniques </span><span class=\"NormalTextRun SCXW141900476 BCX9\" style=\"margin: 0px; padding: 0px; user-select: text;\">can remove the time crunch, make therapies more accessible to a more global patient pool, reduce tissue and organ wastage, all while </span><span class=\"NormalTextRun SCXW141900476 BCX9\" style=\"margin: 0px; padding: 0px; user-select: text;\">tackling the biggest challenge of all to increase </span><span class=\"NormalTextRun SCXW141900476 BCX9\" style=\"margin: 0px; padding: 0px; user-select: text;\">transplant success and improve patient outcomes.</span></span></span></span></p>\n<p><span class=\"TextRun Highlight SCXW141900476 BCX9\" style=\"margin: 0px; padding: 0px; user-select: text; outline: transparent solid 1px; font-variant-ligatures: none !important; color: #000000; font-style: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; white-space: pre-wrap; widows: 2; word-spacing: 0px; background-color: #ffffff; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 11pt; line-height: 17px; font-family: Arial, Arial_EmbeddedFont, Arial_MSFontService, sans-serif;\" lang=\"EN-US\"><span class=\"NormalTextRun SCXW141900476 BCX9\" style=\"margin: 0px; padding: 0px; user-select: text;\">Our overall hypothesis is that organ transport at subzero temperature will <em>fundamentally improve and transform organ preservation</em> by providing greatly extended ischemia windows and higher quality organs by reducing ischemic damage from the time of procurement. Lowering temperature has thus far been the most effective way to slow cellular metabolism and prevent ischemic injury during the preservation of tissues and organs. However, reduction of the storage temperature below 0&deg;C to further extend time leads to an adverse challenge &ndash; freeze damage caused by ice crystals.</span></span></p>\n<p><span class=\"TextRun Highlight SCXW141900476 BCX9\" style=\"margin: 0px; padding: 0px; user-select: text; outline: transparent solid 1px; font-variant-ligatures: none !important; color: #000000; font-style: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; white-space: pre-wrap; widows: 2; word-spacing: 0px; background-color: #ffffff; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 11pt; line-height: 17px; font-family: Arial, Arial_EmbeddedFont, Arial_MSFontService, sans-serif;\" lang=\"EN-US\"><span class=\"NormalTextRun SCXW141900476 BCX9\" style=\"margin: 0px; padding: 0px; user-select: text;\">With this </span><span class=\"NormalTextRun SCXW141900476 BCX9\" style=\"margin: 0px; padding: 0px; user-select: text;\">NSF grant (#1831084), we have demonstrated the use of X-Therma's biomimetic peptoid technology to preserve </span><span class=\"NormalTextRun SCXW141900476 BCX9\" style=\"margin: 0px; padding: 0px; user-select: text;\">some</span><span class=\"NormalTextRun SCXW141900476 BCX9\" style=\"margin: 0px; padding: 0px; user-select: text;\"> of the</span><span class=\"NormalTextRun SCXW141900476 BCX9\" style=\"margin: 0px; padding: 0px; user-select: text;\"> most</span><span class=\"NormalTextRun SCXW141900476 BCX9\" style=\"margin: 0px; padding: 0px; user-select: text;\"> </span><span class=\"NormalTextRun SCXW141900476 BCX9\" style=\"margin: 0px; padding: 0px; user-select: text;\">clinically relevant </span><span class=\"NormalTextRun SCXW141900476 BCX9\" style=\"margin: 0px; padding: 0px; user-select: text;\">tissue-types (full thickness skin and articular cartilage) in an ice-free state of 'suspended animation', rendering the tissues analogous to unpreserved, fresh donor tissue</span><span class=\"NormalTextRun SCXW141900476 BCX9\" style=\"margin: 0px; padding: 0px; user-select: text;\">. The results have </span><span class=\"NormalTextRun SCXW141900476 BCX9\" style=\"margin: 0px; padding: 0px; user-select: text;\">push</span><span class=\"NormalTextRun SCXW141900476 BCX9\" style=\"margin: 0px; padding: 0px; user-select: text;\">ed</span><span class=\"NormalTextRun SCXW141900476 BCX9\" style=\"margin: 0px; padding: 0px; user-select: text;\"> the current limits of </span><span class=\"NormalTextRun SCXW141900476 BCX9\" style=\"margin: 0px; padding: 0px; user-select: text;\">refrigerated tissue </span><span class=\"NormalTextRun SCXW141900476 BCX9\" style=\"margin: 0px; padding: 0px; user-select: text;\">preservation. </span><span class=\"NormalTextRun SCXW141900476 BCX9\" style=\"margin: 0px; padding: 0px; user-select: text;\">In a major milestone, we have for the first time stored human tissue </span><span class=\"NormalTextRun SCXW141900476 BCX9\" style=\"margin: 0px; padding: 0px; user-select: text;\">sourced from </span></span><span class=\"TextRun SCXW141900476 BCX9\" style=\"margin: 0px; padding: 0px; user-select: text; font-variant-ligatures: none !important; color: #000000; font-style: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; white-space: pre-wrap; widows: 2; word-spacing: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 11pt; line-height: 17px; font-family: Arial, Arial_EmbeddedFont, Arial_MSFontService, sans-serif;\" lang=\"EN-US\"><span class=\"NormalTextRun SCXW141900476 BCX9\" style=\"margin: 0px; padding: 0px; user-select: text;\">United States' largest </span><span class=\"NormalTextRun SCXW141900476 BCX9\" style=\"margin: 0px; padding: 0px; user-select: text;\">not-for-profit</span><span class=\"NormalTextRun SCXW141900476 BCX9\" style=\"margin: 0px; padding: 0px; user-select: text;\"> allogenic human tissue bank, AlloSource</span><span class=\"NormalTextRun SCXW141900476 BCX9\" style=\"margin: 0px; padding: 0px; user-select: text;\">. Th</span><span class=\"NormalTextRun SCXW141900476 BCX9\" style=\"margin: 0px; padding: 0px; user-select: text;\">e data acquired will substantially assist the company to establish this product</span><span class=\"NormalTextRun SCXW141900476 BCX9\" style=\"margin: 0px; padding: 0px; user-select: text;\">'s capabilities to </span><span class=\"NormalTextRun SCXW141900476 BCX9\" style=\"margin: 0px; padding: 0px; user-select: text;\">increase the availability of tissues and eradicate the wait-time for organ and tissue transplants not only in the United States, but worldwide.</span></span></p><br>\n<p>\n\t\t\t\t      \tLast Modified: 12/15/2022<br>\n\t\t\t\t\tModified by: Xiaoxi&nbsp;Wei</p>\n</div>\n<div class=\"porSideCol\"></div>\n</div>",
  "por_txt_cntn": "\nOrgan transplantation emerged as a paradigm shift in the treatment of end stage disease when the first kidney transplantation was performed in 1954. Today, the field of organ transplantation has become sophisticated, and patients are now able to benefit from a nationwide organ transplant waiting list currently totaling more than 105,000 individuals.\n\nOrgan- and tissue- preservation and transport is often overlooked, despite a narrow time window that must be adhered to for transplantation success. The quality of organ preservation could be the factor that differentiates a successful therapy from a failed one, and better preservation techniques can remove the time crunch, make therapies more accessible to a more global patient pool, reduce tissue and organ wastage, all while tackling the biggest challenge of all to increase transplant success and improve patient outcomes.\n\nOur overall hypothesis is that organ transport at subzero temperature will fundamentally improve and transform organ preservation by providing greatly extended ischemia windows and higher quality organs by reducing ischemic damage from the time of procurement. Lowering temperature has thus far been the most effective way to slow cellular metabolism and prevent ischemic injury during the preservation of tissues and organs. However, reduction of the storage temperature below 0&deg;C to further extend time leads to an adverse challenge &ndash; freeze damage caused by ice crystals.\n\nWith this NSF grant (#1831084), we have demonstrated the use of X-Therma's biomimetic peptoid technology to preserve some of the most clinically relevant tissue-types (full thickness skin and articular cartilage) in an ice-free state of 'suspended animation', rendering the tissues analogous to unpreserved, fresh donor tissue. The results have pushed the current limits of refrigerated tissue preservation. In a major milestone, we have for the first time stored human tissue sourced from United States' largest not-for-profit allogenic human tissue bank, AlloSource. The data acquired will substantially assist the company to establish this product's capabilities to increase the availability of tissues and eradicate the wait-time for organ and tissue transplants not only in the United States, but worldwide.\n\n\t\t\t\t\tLast Modified: 12/15/2022\n\n\t\t\t\t\tSubmitted by: Xiaoxi Wei"
 }
}